childhood viral diseases Flashcards
measles traits
paramyxovirus -ssRNA genome enveloped virion polymerase is packaged into particle replicate w/in cell humans= only host fusion prot creates syncytia
measles disease progression
inhaled
primary viremia - infection of respiratory ep. tiss (incubation period)
2’ viremia - symptom onset in LN, tonsils, lungs, GI tract and spleen
recovery -20 days after infection
measles sympt. /diagnosis
characteristic rash “koplik spots”
fever, cough, coryza, and conjunctivis
id’ed by culture isolation, serology, ELISA
side effects from measles (!)
immune suppression
opportunistic infections
blindness in vita A deficient children
acute disseminated encyphalomyelitis (neurological)
subacute sclerosing panencephalitis (neurological)
measles prevention
vaccination-live attenuated (life long immunity)
providing vita A to reduce severity (#1 deadly childhood disease)
it’s extremely contagious! 15-20 non-vaccinated people per person
respiratory syncytial virus biology
paramyxovirus -ssRNA enveloped (leaves cell thru budding) replication w/in cell infects ciliated respiatory ep. cells b/c they're colder than rest of body fusion prot. creates syncytia only in humans
respiratory syncytial virus disease traits
inhaled and thru fomites (inannimate obj)
incubation 5 days then upper respiratory then lower respiratory sympt.
recovery after 7-12 days
no life long immunity b/c infects infants w/o good immune syst and only resp syst
risk factors of respiratory syncytial virus disease
day care school aged siblings premature birth, male 2nd hand smoke lack of breast feeding
treatment of respiratory syncytial virus
no vaccine or antivirals
only passive immunoprophylaxis used to prevent
varicella zoster virus biology
alphaherpesvirus dsDNA large - hundreds of proteins enveloped replicates w/in active cell
chickenpox disease
inhaled
incubation period 10-21 days
symptoms fever, malaise, headaache,, rash
recovery = 2 weeks after symptoms but can stay latent an reactivate as shingles
chickenpox prevention
vaccine- life long
antiviral - acyclovir (interfers w/ genome replication)
poliovirus biology
picornavirus \+ssRNA non enveloped replication in cell leaves thru pore in cell membrane humans only
polio disease traits
ingested
minor viremia = infection of peyer’s patches in duodenum
major viremia = 2’ replication
fecal shedding of virus for 6 weeks
polio in CNS
CNS involvement in 1:200
risk factors: physical exertion, trauma and tonsillectomy
replicates in gray matter
causes limb paralysis and sometimes respiratory paralysis